Skip to content
OpenCapital
Get started

Neurocrine Biosciences NBIX Ratios & Valuation

Income StatementBalance SheetCash FlowRatiosSegments
QuarterlyAnnualTTM
YoYQoQ
SimplifiedDetailed
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin98.2%-0.3pp98.2%-0.4pp98.4%-0.2pp98.5%+0.2pp98.5%+0.5pp
Operating margin25.4%+4.9pp21.6%-2.6pp20.5%-5.3pp19.7%-5.6pp20.5%-2.9pp
Net margin21.6%+8.9pp16.7%+2.2pp16%-1.3pp13.9%-2.1pp12.7%-6.0pp
EBITDA margin26.4%+4.7pp22.7%-2.7pp21.6%-5.3pp20.9%-5.6pp21.7%-2.9pp
Free cash flow margin26.8%+6.4pp26.2%+2.5pp22.1%+2.5pp21.1%-2.3pp20.4%-10.6pp
Returns
Return on equity22.5%+10.1pp16.4%+2.2pp15%-1.4pp13.4%-2.2pp12.4%-5.7pp
Return on assets15.6%+7.0pp11.5%+1.7pp11%-1.1pp9.7%-1.8pp8.5%-4.1pp
Return on invested capital17.5%+5.1pp14.4%-0.8pp13%-5.6pp11.8%-5.9pp12.4%-5.5pp
Efficiency
Asset turnover0.7×0.0×0.7×0.0×0.7×0.0×0.7×0.0×0.7×0.0×
Inventory turnover0.9×+0.2×0.8×+0.1×0.8×-0.1×0.8×-0.2×0.7×-0.4×
Liquidity
Current ratio2.9×-0.2×3.4×0.0×3.4×-1.0×3.2×-1.0×3.1×+0.6×
Quick ratio2.9×-0.2×3.3×0.0×3.3×-1.0×3.1×-1.0×3×+0.5×
Cash ratio0.3×-0.1×1×+0.5×0.5×-0.3×0.5×+0.1×0.4×-0.2×
Leverage
Debt-to-equity0.1×-0.1×0.1×0.0×0.2×+0.1×0.2×+0.1×0.2×0.0×
Debt-to-assets0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×0.1×0.0×
Net debt / EBITDA0.2×-0.3×-0.4×-0.8×0.2×+0.3×0.4×+0.2×0.6×+0.5×
Per Share
Book value per share$32.95+33.2%$31.74+27.1%$29.30+12.4%$26.68+10.5%$24.74+7.4%
Valuation
Market capitalization$13.22B+19.9%$14.14B+2.3%$13.92B+19.9%$12.69B-7.7%$11.03B-19.9%
Enterprise value$13.41B+18.5%$13.89B-1.3%$14.05B+21.8%$12.9B-7.1%$11.32B-17.8%
Price / earnings19.8×-16.3×29.5×-10.9×32.5×+2.4×36.4×-4.1×36.1×-1.2×
Price / sales4.3×-0.3×4.9×-0.9×5.2×0.0×5.1×-1.4×4.6×-2.4×
Price / book3.9×-0.5×4.3×-1.0×4.6×+0.4×4.7×-0.8×4.3×-1.4×
EV / EBITDA16.4×-5.2×21.4×-2.2×24.2×+5.1×24.6×-0.1×21.6×-6.7×
EV / sales4.3×-0.4×4.9×-1.1×5.2×+0.1×5.1×-1.4×4.7×-2.3×
Free cash flow yield6.3%+1.8pp5.3%+1.3pp4.3%+0.5pp4.2%+0.6pp4.5%0.0pp
Earnings yield5.1%+2.3pp3.4%+0.9pp3.1%-0.2pp2.7%+0.3pp2.8%+0.1pp
PEG ratio0.2×—0.7×-0.4×3×+2.7×13.6×+13.1×——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Neurocrine Biosciences's profit margins?
Neurocrine Biosciences (NBIX) runs a 98.2% gross margin and a 25.4% operating margin, with a 21.6% net margin.
Where do Neurocrine Biosciences's ratios come from?
Every ratio is computed from Neurocrine Biosciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.